PHH

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Jim SimonsRenaissance Technologies $-54.2K ExitQ1 2026 $54k -- $0.385
Ken GriffinCitadel Advisors $-14.9K ExitQ1 2026 $15k -- $0.385
Ken GriffinCitadel Advisors $-743.0K ExitQ3 2025 $743k -- $0.385
Ken GriffinCitadel Advisors $523.4K AddQ2 2025 $523k -- $0.385
Ken GriffinCitadel Advisors $32.5K AddQ1 2025 $32k -- $0.385

News

globenewswire.comPHH Mortgage Receives 2025 Fannie Mae Star Performer Award for Servicing Excellenceglobenewswire.comMar 12

Trade PHH

About Park Ha Biological Technology Co., Ltd.

Park Ha Biological Technology Co., Ltd., an investment holding firm, is primarily engaged in the creation and development of skincare products within the People's Republic of China. The company's operations are divided into two core areas: direct product sales and a franchise service model. Under its own 'Park Ha' brand, the company offers a comprehensive selection of skincare solutions. These products cater to a spectrum of dermatological needs, ranging from fundamental physical skin protection and exfoliation to repairing the sebum film, achieving surface microecological balance, and providing anti-aging treatments. Park Ha Biological Technology distributes its merchandise to consumers through both its company-owned retail outlets and an extensive network of franchised partners. Established in 2016, the firm's main office is situated in Wuxi, PRC. It operates as a subsidiary of Xiaoqiu Holding Ltd.

CEO: Xiaoqiu Zhang
IPO Date: Jan 19, 2005

Market Data

Open: $0.3916
High: $0.4235
Low: $0.3825
Volume: 428.9K
52W High: $41.49
52W Low: $0.331

Valuation

Market Cap: $10.0M
Enterprise Value: $-2.6M

Financials

Free Cash Flow: $875k
Revenue: $2.4M
Net Income: $479k
Cash: $547k
Debt: $70k

Events

EarningsJun 30

EPS est. -1.3548 · actual -1.07136